Integra Lifesciences Holdings (IART) Net Equity Issued and Repurchased (2015 - 2018)
Integra Lifesciences Holdings (IART) posted Net Equity Issued and Repurchased of -$9000.0 for Q3 2018, up 95.89% sequentially from -$219000.0 in Q4 2015.
Integra Lifesciences Holdings (IART) Net Equity Issued and Repurchased (2015 - 2018) Analysis & Trends
Integra Lifesciences Holdings has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at -$9000.0 in Q3 2018.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$9000.0 in Q3 2018, while the trailing twelve-month figure through Dec 2019 was -$9000.0 (changed 0.0% YoY) and the FY2018 annual result came in at $349.6 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to -$9000.0 in Q3 2018 per IART's latest filing, from -$219000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at -$9000.0 in Q3 2018 and troughed at -$219000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -9,000.00 |
| Sep 30, 2018 | -9,000.00 |
| Dec 31, 2015 | -219,000.00 |
| Dec 31, 2015 | -219,000.00 |